文献速递生殖医学

肌酸延长精子获能持续时间:改善少精子体外受精的新因素

Creatine enhances the duration of sperm capacitation: a novel factor for improving in vitro fertilization with small numbers of sperm.
PubMed 文献 · Hum Reprod · 2018-01-01

小鼠研究表明,排卵后输卵管肌酸水平显著升高,肌酸拮抗剂GPA注射可显著减少受精卵数;在IVF培养基中添加肌酸可通过增加ATP水平增强精子获能,使每卵仅5条精子即可成功受精,且受精卵数显著高于无肌酸对照组(P < 0.01)。作者认为含肌酸培养基的改良IVF技术对少精子患者的人类辅助生殖技术可能有益。

要点

  • 排卵后输卵管肌酸水平显著升高,肌酸拮抗剂GPA注射显著减少受精卵数。
  • IVF培养基中添加肌酸通过增加ATP水平增强精子获能。
  • 含肌酸组每卵仅5条精子即可成功受精,受精卵数显著高于无肌酸对照组(P < 0.01)。

核心结论

  • 卵巢产生的肌酸在体内促进高效受精,而体外受精培养基中不含肌酸。
  • 使用含肌酸培养基的改良IVF技术可显著改善少精子条件下的受精。
  • 作者认为该方法对人类辅助生殖技术可能有益,尤其适用于优质精子数量有限的患者。

研究设计与样本

  • 研究收集卵泡液和输卵管液并分析肌酸与葡萄糖水平。
  • 将肌酸拮抗剂3-胍基丙酸(GPA)注射入激素预处理小鼠以确定肌酸的生理功能。
  • 采用常规IVF方案,精子在含肌酸的IVF培养基中预孵育后与10个排卵的卵丘-卵母细胞复合体共培养(每卵1-1000条精子),置于50 μl培养基微滴中。
  • 通过交配实验评估GPA处理与否对体内肌酸作用的影响。
  • 采用计算机辅助精子分析、蛋白质印迹分析和花生凝集素-FITC染色分别评估精子活力、获能水平和顶体状态。

主要发现

  • 排卵后输卵管肌酸水平显著升高。
  • 排卵前注射GPA的小鼠受精卵数显著减少。
  • IVF培养基中添加肌酸通过增加ATP水平增强精子获能。
  • 含肌酸组每卵仅5条精子即可成功受精,受精卵数显著高于无肌酸对照组(P < 0.01)。

临床怎么用

  • 作者认为含肌酸培养基的改良IVF技术对人类辅助生殖技术可能有益,尤其适用于优质精子数量有限的患者;原文未据此给出推荐。

局限性

  • 本研究使用药理方法(肌酸拮抗剂GPA处理)而非基因敲除小鼠模型来理解肌酸在体内的作用。
  • 肌酸在受精过程中的作用仅能在小鼠模型中显示。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Why are many sperm required for successful fertilization of oocytes in vitro, even though fertilization occurs in vivo when only a few sperm reach the oocyte? SUMMARY ANSWER: Creatine produced in the ovary promotes efficient fertilization in vivo; however, in vitro, creatine is not contained in the in vitro fertilization (IVF) medium. WHAT IS KNOWN ALREADY: The IVF medium enables capacitation of sperm. However, the IVF medium does not fully mimic the in vivo environment during fertilization. Consequently, fertilization in vitro is more inefficient than in the oviduct. STUDY DESIGN, SIZE, DURATION: Follicular and oviductal fluids were collected and then analyzed for creatine and glucose levels. To determine the physiological functions of creatine, the creatine antagonist 3-guanidinopropionic acid (GPA) was injected into hormonally primed mice. Using conventional IVF protocols, sperm were pre-incubated in IVF medium with creatine and then co-cultured with 10 ovulated cumulus-oocyte complexes (1-1000 per oocyte) in 50 μl medium droplets. PARTICIPANTS/MATERIALS, SETTING, METHODS: Glucose and creatine levels were measured using commercial enzymatic assay kits. The effect of creatine in vivo was assessed by mating experiments using mice treated with or without GPA just before ovulation. To assess the functions of sperm incubated in IVF medium containing creatine, we analyzed (1) the motility of sperm using computer-assisted sperm assay, (2) the capacitation level of sperm by western blot analyses, and (3) the condition of sperm acrosomes by peanut agglutinin lectin-FITC staining. MAIN RESULTS AND THE ROLE OF CHANCE: Oviductal creatine levels were significantly increased following ovulation. Injecting mice with GPA just before ovulation significantly reduced the number of fertilized oocytes. The addition of creatine to IVF medium enhanced sperm capacitation by increasing ATP levels. Successful fertilization was achieved with as few as five sperm/oocyte in the creatine group, and the number of fertilized oocytes was significantly higher than in the control without creatine (P < 0.01). LIMITATIONS, REASONS FOR CAUTION: In the present study, a pharmacological approach, creatine antagonist (GPA) treatment, but not a knockout mouse model, was used to understand the role of creatine in vivo. The role of creatine in fertilization processes can only be shown in a mouse model. WIDER IMPLICATIONS OF THE FINDINGS: A modified IVF technique using creatine-containing medium was developed and shown to markedly improve fertilization with small numbers of sperm. This approach has the potential to be highly beneficial for human assisted reproductive technologies, especially for patients with a limited number of good quality sperm. STUDY FUNDING/COMPETING INTEREST(S): This work was supported in part by JSPS KAKENHI Grant numbers JP24688028, JP16H05017 (to M.S.), and JP15J05331 (to T.U.), the Japan Agency for Medical Research and Development (AMED) (16gk0110015h0001 to M.S.), and National Institutes of Health (NIH-HD-076980 to J.S.R). The authors have nothing to disclose.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Umehara T, Kawai T, Goto M, et al. Creatine enhances the duration of sperm capacitation: a novel factor for improving in vitro fertilization with small numbers of sperm. Hum Reprod. 2018. PMID: 29635630. doi:10.1093/humrep/dey081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。